Total Payments
$1,079
2024 Payments
$592.81
Companies
15
Transactions
61
Medicare Patients
2,200
Medicare Billing
$140,778
Payment Breakdown by Category
Food & Beverage$1,009 (93.5%)
Education$69.95 (6.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,009 | 60 | 93.5% |
| Education | $69.95 | 1 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $284.00 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $149.36 | 5 | $0 (2024) |
| PFIZER INC. | $146.10 | 9 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $113.40 | 1 | $0 (2022) |
| UCB, Inc. | $75.72 | 4 | $0 (2024) |
| ABBVIE INC. | $61.85 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $60.58 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $44.01 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32.49 | 1 | $0 (2024) |
| Allergan Inc. | $24.18 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $592.81 | 32 | Amgen Inc. ($93.61) |
| 2022 | $113.40 | 1 | Aurinia Pharma U.S., Inc. ($113.40) |
| 2020 | $15.55 | 1 | Amgen Inc. ($15.55) |
| 2019 | $250.81 | 23 | Amgen Inc. ($174.84) |
| 2017 | $105.93 | 4 | Janssen Biotech, Inc. ($69.95) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Rare Disease | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Immunology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Immunology | ||||||
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Immunology | ||||||
| 11/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $15.38 | General |
| 11/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Bone Health | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Immunology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $25.70 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 10/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Immunology | ||||||
| 10/02/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 385 | 494 | $103,199 | $27,017 |
| 2022 | 6 | 473 | 654 | $134,807 | $32,115 |
| 2021 | 9 | 618 | 770 | $156,712 | $39,446 |
| 2020 | 10 | 724 | 912 | $175,651 | $42,200 |
Total Patients
2,200
Total Services
2,830
Medicare Billing
$140,778
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 141 | $42,415 | $10,491 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $26,349 | $6,485 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 65 | $12,660 | $3,633 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 27 | $6,183 | $1,938 | 31.3% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 34 | 34 | $5,544 | $1,499 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $4,524 | $1,222 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 99 | 146 | $2,026 | $1,219 | 60.2% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 12 | 12 | $3,498 | $528.27 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 188 | $57,340 | $14,787 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $40,162 | $8,828 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 74 | $15,318 | $4,202 | 27.4% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 55 | 55 | $9,072 | $2,263 | 24.9% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 35 | 35 | $10,971 | $1,402 | 12.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 129 | 216 | $1,944 | $632.94 | 32.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 165 | $50,325 | $14,259 | 28.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 121 | 121 | $56,507 | $13,556 | 24.0% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2021 | 78 | 82 | $12,684 | $3,549 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 71 | $14,697 | $3,508 | 23.9% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 46 | 48 | $14,469 | $2,073 | 14.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 16 | 16 | $3,440 | $1,044 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 154 | 232 | $2,088 | $693.48 | 33.2% |
| 73565 | X-ray of both knees, standing, front to back view | Office | 2021 | 16 | 16 | $1,552 | $465.72 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 19 | $950.00 | $296.78 | 31.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 162 | 162 | $75,654 | $18,768 | 24.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 101 | $30,889 | $7,417 | 24.0% |
About Dr. Charles Moore, M.D
Dr. Charles Moore, M.D is a Internal Medicine healthcare provider based in New Albany, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740209253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Moore, M.D has received a total of $1,079 in payments from pharmaceutical and medical device companies, with $592.81 received in 2024. These payments were reported across 61 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,009).
As a Medicare-enrolled provider, Moore has provided services to 2,200 Medicare beneficiaries, totaling 2,830 services with total Medicare billing of $140,778. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology, Hospitalist
- Location New Albany, IN
- Active Since 07/18/2006
- Last Updated 03/05/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1740209253
Products in Payments
- Enbrel (Biological) $194.03
- XELJANZ (Drug) $146.10
- LUPKYNIS (Drug) $113.40
- TREMFYA (Drug) $79.41
- Bimzelx (Biological) $75.72
- STELARA (Biological) $69.95
- RINVOQ (Biological) $61.85
- EVENITY (Biological) $45.78
- ORENCIA (Biological) $44.01
- BENLYSTA (Biological) $38.92
- SAPHNELO (Biological) $32.49
- STRENSIQ (Biological) $22.43
- TRELEGY ELLIPTA (Drug) $21.66
- Actemra (Biological) $19.00
- KINERET (Drug) $18.13
- TALTZ (Drug) $15.45
- BYSTOLIC (Drug) $13.62
- TAVNEOS (Drug) $13.26
- ORBACTIV (Drug) $11.80
- VIBERZI (Drug) $10.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Albany
Dr. Thomas Barkley, M.d, M.D
Internal Medicine — Payments: $4,589
Internal Medicine $4,589
Dr. Thomas Shands, Md, MD
Internal Medicine — Payments: $4,528
Internal Medicine $4,528
Dr. Douglas Bickers, Md, MD
Internal Medicine — Payments: $3,711
Internal Medicine $3,711
Dr. Allie Prater, M.d, M.D
Internal Medicine — Payments: $2,921
Internal Medicine $2,921
Allen Lewis, D.o, D.O
Internal Medicine — Payments: $1,814
Internal Medicine $1,814
Viktor Miro, M.d, M.D
Internal Medicine — Payments: $923.71
Internal Medicine $923.71